Scientists Working To Understand Immunity To Novel Coronavirus, Whether Patients’ Infections Can ‘Reactivate’

Scientific American: What Immunity to COVID-19 Really Means
“…At this early stage of understanding the new coronavirus, it is unclear where COVID-19 falls on the immunity spectrum. Although most people with SARS-CoV-2 seem to produce antibodies, ‘we simply don’t know yet what it takes to be effectively protected from this infection,’ says Dawn Bowdish, a professor of pathology and molecular medicine and Canada Research Chair in Aging and Immunity at McMaster University in Ontario. Researchers are scrambling to answer two questions: How long do SARS-CoV-2 antibodies stick around? And do they protect against reinfection?…” (McKenna, 4/10).

Bloomberg: Coronavirus May ‘Reactivate’ in Cured Patients, Korean CDC Says (Park, 4/9).

Financial Times: Mystery surrounds ‘cured’ patients who tested positive (White/Jung-a, 4/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.